Test ID: HLA57
HLA-B 5701 Genotype, Abacavir Hypersensitivity, Blood
Secondary ID
A test code used for billing and in test definitions created prior to November 2011
89346
NY State Approved
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For
Suggests clinical disorders or settings where the test may be helpful
Assisting a physician in developing a therapeutic management strategy for HIV-infected patients
Predicting likelihood of hypersensitivity reactions to abacavir in HIV-infected patients, based on the presence of the human leukocyte antigen HLA-B*5701 allele
Aiding in differentiating between true hypersensitivity to abacavir versus other underlying causes (eg, concomitant infection, reaction to other drugs, or inflammatory disease)
Testing Algorithm
Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
See Abacavir Hypersensitivity Testing and Initial Patient Management Algorithm in Special Instructions
Special Instructions and Forms
Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name
A short description of the method used to perform the test
Qualitative Allele-Specific Real-Time Polymerase Chain Reaction (PCR)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name
A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
HLA-B 5701 Genotype, Abacavir, B
Aliases
Lists additional common names for a test, as an aid in searching
Abacavir Hypersensitivity
HLA B
HLA B57
HLA B5701
HLA-B57
HLA-B57.1
HLAB
HLAB5701
HLA B
HLA B57
HLA B5701
HLA-B57
HLA-B57.1
HLAB
HLAB5701


